Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Polycystic Ovary Syndrome 4Prostatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Rectal Neoplasms 1Psoriasis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasms 1Neoplasm, Residual 1Multiple Sclerosis 1Lipid Metabolism Disorders 1Inflammation 1Healthy Subject 1Dyspareunia 1Diabetes Mellitus 1Crohn Disease 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Breast Feeding 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Aggressive Periodontitis 1

Interventions

Cyclophosphamide 7blinatumomab 6Cytarabine 6fludarabine 5Mercaptopurine 5Methotrexate 4fludarabine phosphate 3Vincristine 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Drug Therapy 3Dexamethasone 3Daunorubicin 3Asparaginase 3Whole-Body Irradiation 2Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Interleukin-2 2Doxorubicin 2Cladribine 2Blood Specimen Collection 2Azacitidine 2tisagenlecleucel 1thymoglobulin 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm, Residual × Fish Oils × Clear all
NCT03093207 2020-11-17

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Universidade Estadual Paulista Júlio de Mesquita Filho

Phase 2/3 Completed
34 enrolled 8 charts

Aggressive Periodontitis, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡